Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Syndax Pharmaceuticals (SNDX) FCF Margin (2016 - 2020)

Syndax Pharmaceuticals (SNDX) has disclosed FCF Margin for 6 consecutive years, with 4113.42% as the latest value for Q4 2020.

  • For Q4 2020, FCF Margin fell 76421.0% year-over-year to 4113.42%; the TTM value through Sep 2021 reached 22949.74%, down 1844374.0%, while the annual FY2025 figure was 187.5%, 97340.0% up from the prior year.
  • FCF Margin hit 4113.42% in Q4 2020 for Syndax Pharmaceuticals, up from 4827.7% in the prior quarter.
  • Across five years, FCF Margin topped out at 1069.91% in Q4 2017 and bottomed at 5648.28% in Q2 2020.
  • Average FCF Margin over 5 years is 3715.02%, with a median of 3915.61% recorded in 2017.
  • Year-over-year, FCF Margin soared 2120326bps in 2016 and then tumbled -289246bps in 2018.
  • Syndax Pharmaceuticals' FCF Margin stood at 3415.08% in 2016, then soared by 69bps to 1069.91% in 2017, then plummeted by -270bps to 3962.37% in 2018, then grew by 15bps to 3349.21% in 2019, then dropped by -23bps to 4113.42% in 2020.
  • According to Business Quant data, FCF Margin over the past three periods came in at 4113.42%, 4827.7%, and 5648.28% for Q4 2020, Q3 2020, and Q2 2020 respectively.